Zhi Wang, Xudong Zhao, Wenchao Du, Xiaoliang Zhang, Xingxing Li, Linquan Wang
{"title":"Prevention and management strategies of anal squamous cell carcinoma among men who have sex with men living with HIV.","authors":"Zhi Wang, Xudong Zhao, Wenchao Du, Xiaoliang Zhang, Xingxing Li, Linquan Wang","doi":"10.1177/09564624251333035","DOIUrl":"10.1177/09564624251333035","url":null,"abstract":"<p><p>The incidence of anal squamous cell carcinoma (SCCA) has been rapidly increasing in recent years. The burden of the disease is expected to increase in the forthcoming years. Men who have sex with men living with HIV (MSMLWH) have a higher incidence of SCCA than the general population. The progression of SCCA usually develops from high risk human papillomavirus (HR-HPV) infection to high grade squamous intra-epithelial lesions (HSIL). HPV infection is highly prevalent in MSMLWH and is considered the most important risk factor for SCCA in MSMLWH. Although the prevalence worldwide is largely similar, the distribution of high-risk HPV genotypes varies. Education on sexuality and lifestyle, use of condoms, fixed sexual partner, effective antiretroviral therapy (ART), smoking cessation, and preventive male circumcision could reduce HPV infection in MSMLWH. Screening and treatment of HSIL have been widely applied to prevent SCCA, but divergence still exists in many studies. When treating HSIL, patients of different ages and risk factors need more consideration to develop standardized management strategies, especially for MSMLWH. Very few studies have examined the treatment of SCCA with MSMLWH. ART has dramatically changed the treatment of SCCA in MSMLWH. The safety and outcome of treatment are still primary concerns for MSMLWH. More studies in this field are necessary to develop treatment strategies for MSMLWH.</p>","PeriodicalId":14408,"journal":{"name":"International Journal of STD & AIDS","volume":" ","pages":"533-541"},"PeriodicalIF":1.4,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143982873","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Reducing non-sterile glove use in a sexual health and HIV department: A quality improvement project to address clinical practices.","authors":"Laurie Smith, Amanda Clarke, Gillian Dean","doi":"10.1177/09564624251326696","DOIUrl":"10.1177/09564624251326696","url":null,"abstract":"<p><p>BackgroundClimate change is a huge public health threat, necessitating reductions in carbon emissions, particularly from single-use plastics like non-sterile gloves (NSG). This quality improvement project aims to explore whether use of targeted educational material changes staff attitudes towards NSG use in clinical practice within a Sexual Health and HIV department.MethodsA pre-intervention survey was circulated to all clinicians. Subsequently, various methods encouraged appropriate NSG use including video guidance of performing venepuncture without gloves in line with Trust policy, educational presentations, and patient-facing posters for waiting rooms. NSG procurement data were obtained, and a post-intervention survey evaluated whether NSG use had changed following the interventions.ResultsSixty-three percent of staff believed they had reduced their personal glove use in the past year. Many staff believed the best way to reduce inappropriate glove use was through education as well as empowering patients through posters. Glove procurement data comparing 2023/2024 to pre-COVID 2019/2020 showed a 45.2% decrease in NSG orders from 173,110 to 94,800 per year.ConclusionsStaff education is successful in reducing inappropriate NSG use, with patient posters and targeted staff presentations the most effective measures to drive behaviour change and therefore reduce NSG use.</p>","PeriodicalId":14408,"journal":{"name":"International Journal of STD & AIDS","volume":" ","pages":"583-586"},"PeriodicalIF":1.4,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12085747/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143624747","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Aude Van Oosterwyck, Eric Van Wijngaerden, Philip Roelandt
{"title":"A male patient with <i>Chlamydia</i> peritonitis: Case report.","authors":"Aude Van Oosterwyck, Eric Van Wijngaerden, Philip Roelandt","doi":"10.1177/09564624251329633","DOIUrl":"10.1177/09564624251329633","url":null,"abstract":"<p><p>Pelvic inflammatory disease (PID) is a well-known entity in women. However, on rare occasions, men can present with peritonitis caused by <i>Chlamydia trachomatis</i> as well. It is important to know and recognise this entity in order to avoid unnecessary investigations and commence prompt treatment.</p>","PeriodicalId":14408,"journal":{"name":"International Journal of STD & AIDS","volume":" ","pages":"595-596"},"PeriodicalIF":1.4,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143729991","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Paige Neuenschwander, Andrea Norcini Pala, Fredrick L Altice, Robert H Remien, Gaukhar Mergenova, Elena Rozental, Valeriy Gulyayev, Alissa Davis
{"title":"Impact of multi-level factors and partner characteristics on antiretroviral therapy adherence and access to HIV care during the COVID-19 pandemic.","authors":"Paige Neuenschwander, Andrea Norcini Pala, Fredrick L Altice, Robert H Remien, Gaukhar Mergenova, Elena Rozental, Valeriy Gulyayev, Alissa Davis","doi":"10.1177/09564624251329626","DOIUrl":"10.1177/09564624251329626","url":null,"abstract":"<p><p>BackgroundAdherence to antiretroviral therapy (ART) remains a challenge for many people with HIV and was exacerbated during the COVID-19 pandemic. This paper examines factors associated with ART adherence among people with HIV who inject drugs (PWHWID) in Almaty, Kazakhstan during the COVID-19 pandemic.MethodsA cross-sectional survey was conducted from October 2020 to August 2022 with 66 PWHWID and their treatment support partners (<i>n</i> = 66) to assess associations between ART adherence and sociodemographic, COVID-19 related, social support, and other factors. Multilevel generalized linear mixed models were used to examine factors associated with optimal (≥90%) and standard (≥80%) adherence levels.ResultsWe found low medication adherence rates: only 55.8% took ≥80% of their doses, and just 14.7% took ≥90%. People were more likely to take their medication consistently if they had a partner with HIV, experienced less household conflict during COVID-19, or met with addiction professionals. Poor mental health and negative emotional impacts from COVID-19 were associated with low adherence.ConclusionThese findings suggest that HIV treatment programs should consider the importance of patients' relationship factors, mental health, and home environment impacts during public health crises.</p>","PeriodicalId":14408,"journal":{"name":"International Journal of STD & AIDS","volume":" ","pages":"568-576"},"PeriodicalIF":1.4,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143742926","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"\"Are new lipid lowering agents a good option for achieving lipid goals in people living with HIV? A case report\".","authors":"Raffaele Ferri, Katia Falasca, Jacopo Vecchiet, Claudio Ucciferri","doi":"10.1177/09564624251327237","DOIUrl":"10.1177/09564624251327237","url":null,"abstract":"<p><p>The dyslipidemia in people living with HIV differs from the general population because combination antiretroviral therapy may not only induce dyslipidemia but also interact with lipid-lowering agents.Monoclonal antibodies that target proprotein convertase subtilisin/kexin type 9 (PCSK9) have recently been demonstrated to dramatically reduce LDL-C level (>60%) in the majority of cases, and another interesting new option is inclisiran, a first-in-class, cholesterol-lowering small interfering RNA (siRNA) targeting PCSK9 mRNA and conjugated to triantennary N-acetylgalactosamine carbohydrates (GalNAc).We present the clinical case of a 62-year-old man living with HIV and dyslipidemia in whom new hypolipidemic drugs were fundamental in achieving adequate LDL values to prevent cardiovascular events.</p>","PeriodicalId":14408,"journal":{"name":"International Journal of STD & AIDS","volume":" ","pages":"591-594"},"PeriodicalIF":1.4,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143692167","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Asymptomatic viral shedding of mpox virus: What do we know?","authors":"Sara Almarzooqi","doi":"10.1177/09564624251332716","DOIUrl":"10.1177/09564624251332716","url":null,"abstract":"","PeriodicalId":14408,"journal":{"name":"International Journal of STD & AIDS","volume":" ","pages":"597-598"},"PeriodicalIF":1.4,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143763821","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Georgina Morris, Lewis Haddow, Parameswaran N Sashidharan, Amber Savary-Trathen, Suneeta Soni, Charlotte Bigland, Hasan Mirza, Stephen L Walker
{"title":"British Association for Sexual Health and HIV National Guideline on the Management of Scabies in adults 2025.","authors":"Georgina Morris, Lewis Haddow, Parameswaran N Sashidharan, Amber Savary-Trathen, Suneeta Soni, Charlotte Bigland, Hasan Mirza, Stephen L Walker","doi":"10.1177/09564624251321264","DOIUrl":"10.1177/09564624251321264","url":null,"abstract":"<p><p>The British Association for Sexual Health and HIV UK guideline on the management of scabies has been updated in 2025. It provides details on the pathology and clinical features of scabies, with evidence-informed, practical recommendations on diagnosis, treatment and follow-up of adults and children aged 13 or above attending sexual health services. Key updates are detailed at the start of the article.</p>","PeriodicalId":14408,"journal":{"name":"International Journal of STD & AIDS","volume":" ","pages":"516-532"},"PeriodicalIF":1.4,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143657124","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Vivian I Avelino-Silva, Alexander Goncalvez, Whitney Engeran, Laura Boudreau, Michael Weinstein, Adele Schwartz Benzaken
{"title":"Expanding access to STI care with free of charge, convenient services in sexual health walk-in clinics.","authors":"Vivian I Avelino-Silva, Alexander Goncalvez, Whitney Engeran, Laura Boudreau, Michael Weinstein, Adele Schwartz Benzaken","doi":"10.1177/09564624251325310","DOIUrl":"10.1177/09564624251325310","url":null,"abstract":"<p><p><b>Background:</b> Sexually transmitted infections (STIs) are a long-standing public health issue with increasing incidence in recent years even though most STIs can be effectively treated or even cured with inexpensive medications.<b>Purpose/Design:</b> In this manuscript, we discuss factors that contribute with this concerning scenario, including modifications in the model of STI care in the United States; barriers for diagnosis and treatment; and scarcity of targeted STI prevention messages. We then describe the approach adopted by AIDS Healthcare Foundation to mitigate STI trends, with a focus on sexual health Wellness Centers.<b>Results:</b> The main characteristics of this program include free and convenient services with large volume capacity, sex-positive culture, advertisement of available resources, and accessibility to key populations at higher risk for STI acquisition.<b>Conclusions:</b> This experience could be adapted and expanded to other settings, supporting the public health mission of controlling the spread and detrimental outcomes of STIs.</p>","PeriodicalId":14408,"journal":{"name":"International Journal of STD & AIDS","volume":" ","pages":"587-590"},"PeriodicalIF":1.4,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12085745/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143605076","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Jaiberth Antonio Cardona-Arias, Paula Andrea Álvarez Cossio, Angélica María Mancera Mieles, Laura Navales Balbín, Luis Felipe Higuita Gutiérrez
{"title":"Prevalence of HIV in sex workers attended in a health institution in Medellín, Colombia.","authors":"Jaiberth Antonio Cardona-Arias, Paula Andrea Álvarez Cossio, Angélica María Mancera Mieles, Laura Navales Balbín, Luis Felipe Higuita Gutiérrez","doi":"10.1177/09564624251330011","DOIUrl":"10.1177/09564624251330011","url":null,"abstract":"<p><p>BackgroundDespite being a key group for infection control, research on the prevalence of human immunodeficiency virus (HIV) among female sex sorkers (FSWs) in Colombia is scarce and outdated.MethodsThis is a prevalence study involving 739 FSWs who attended a healthcare provider in Medellín between 2019 and 2023. Data were collected from medical records to capture sociodemographic and health information. The prevalence of HIV was determined with its 95% confidence interval, and comparisons of HIV prevalence with sociodemographic and behavioral factors were conducted using Fisher's exact test and prevalence ratios. Analyses were performed using SPSS 29.0.ResultsMost FSWs had a primary education or less, and 50% were enrolled in the contributory health regime. Sixty-two percent reported using hallucinogens during sex, and 17% had relationships with individuals diagnosed with Sexually Transmitted Infections (STIs). The prevalence of HIV was 1.4%, with a higher prevalence among those with a previous STI diagnosis, at 12%. No significant differences were found based on other sociodemographic or behavioral variables.ConclusionThis study reveals a higher HIV prevalence compared to previous studies among FSWs, indicating the need for new health programs specifically tailored for this group, particularly for women with prior STIs, as they represent a key population for HIV infection that demands better healthcare approaches. Additionally, further research is needed to understand how sociodemographic changes impact infection dynamics in this population.</p>","PeriodicalId":14408,"journal":{"name":"International Journal of STD & AIDS","volume":" ","pages":"577-582"},"PeriodicalIF":1.4,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143752710","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}